Kala Pharmaceuticals Inc (KALA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $89,480
Last updated: Nov 17, 2026 at 10:57 AM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 805.0% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 96.4, above 70, the overbought line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about KALA
News
KALA Valuation
- P/B
- 0.0x
KALA Profitability: Margins, ROIC and FCF
Kala Pharmaceuticals (KALA) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -345.3%
Kala Pharmaceuticals Competitors
The companies most similar to Kala Pharmaceuticals (KALA) include Karyopharm Therapeutics, Kalaris Therapeutics and Kiora Pharmaceuticals.
Sector: Healthcare
Companies most similar to Kala PharmaceuticalsKALA Bull Case vs Bear Case
Bull case
- KALA beat EPS estimates in 75.0% of its last 8 reported quarters.
Bear case
- KALA's quarterly revenue changed -100.0% year over year.
KALA Earnings: Beat Rate
Kala Pharmaceuticals (KALA) beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate (75.0%). Its next report is expected on Nov 17, 2026.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 28.8%
KALA Earnings Date
KALA reports Nov 17, 2026. The date is estimated.
Updated Aug 19, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About KALA
When does KALA report earnings?
Kala Pharmaceuticals Inc (KALA) is expected to report earnings on Nov 17, 2026.
Does KALA pay dividends?
Kala Pharmaceuticals Inc (KALA) does not currently pay a regular dividend.
What is KALA's market cap?
Kala Pharmaceuticals Inc (KALA) has a market capitalization of $89,480 with a current stock price of $3.56.
KALA pages: Overview, Earnings, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.